Clinical Trial Update: Trial of the Effect of Low-Molecular-Weight Heparin (LMWH) Versus Warfarin on Mortality in the Long-Term Treatment of Proximal Deep Vein Thrombosis (DVT) (Main LITE Study) [Phase 4]

View source ↗

Summary

The Main LITE study comparing low-molecular-weight heparin to warfarin for long-term treatment of proximal deep vein thrombosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Deep Vein Thrombosis
• Venous Thromboembolism

Drugs mentioned

• Low molecular weight heparin (low molecular weight heparin)
• Warfarin (warfarin)

Snippet

Sponsor: University of Calgary | Conditions: Thrombosis, Thromboembolism | Phase 4 | Status: COMPLETED